Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Stewart V. Nelson who wrote (2125)	2/25/1999 10:06:00 PM
From: Joe	Respond to of 4140

Stewart, I am not sure there is any point in responding to you. But for what it is worth, Sunrise has already received the proceeds from the sale of the stock being registered. The last two placements being registered generated $11.8M and $10M in cash that went into the coffers at SNRS. The funding for completion of clinical trials, FDA submission of the PMA and readying their new LTK system for production upon FDA approval costs money and it must come from somewhere. Joe